We are live on ! Find out more
MRNS

Marinus Pharmaceuticals, Inc
MRNS

Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

18 hedge funds and large institutions have $34.8M invested in Marinus Pharmaceuticals, Inc in 2014 Q3 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CPV
Canaan Partners VII
Connecticut
+$19M
2
Franklin Resources
Franklin Resources
California
+$10.7M
3
PI
Putnam Investments
Massachusetts
+$2.32M
4
SFM
Sphera Funds Management
Israel
+$2.27M
5
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
+$2.06M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CPV
1
Canaan Partners VII
Connecticut
$15.9M +$19M +615,350 New
Franklin Resources
2
Franklin Resources
California
$8.99M +$10.7M +347,375 New
PI
3
Putnam Investments
Massachusetts
$1.94M +$2.32M +75,000 New
SFM
4
Sphera Funds Management
Israel
$1.9M +$2.27M +73,383 New
AWMDMG
5
Austin W. Marxe & David M. Greenhouse
New York
$1.73M +$2.06M +66,834 New
BBA
6
Baker Bros. Advisors
New York
$1.32M +$1.58M +51,119 New
EA
7
Emerald Advisers
Pennsylvania
$1.02M +$1.22M +39,385 New
EMFAT
8
Emerald Mutual Fund Advisers Trust
Pennsylvania
$935K +$1.12M +36,115 New
Bank of America
9
Bank of America
North Carolina
$434K +$518K +16,767 New
Goldman Sachs
10
Goldman Sachs
New York
$342K +$409K +13,227 New
Millennium Management
11
Millennium Management
New York
$117K +$140K +4,516 New
SIM
12
Spark Investment Management
New York
$77K +$93.1K +3,015 New
TRCT
13
Tower Research Capital (TRC)
New York
$33K +$39.9K +1,293 New
Morgan Stanley
14
Morgan Stanley
New York
$10K +$11.7K +380 New
BIM
15
BlackRock Investment Management
Delaware
$6K +$6.92K +224 New
GSC
16
Ground Swell Capital
South Carolina
$4K +$4.39K +142 New
Deutsche Bank
17
Deutsche Bank
Germany
$2K +$3.09K +100 New
U
18
UBS
Switzerland
$1K +$1.24K +40 New

MRNS Hedge Fund Activity: Q3 2014 in Review

18 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Marinus Pharmaceuticals, Inc (MRNS) for Q3 2014, worth a combined $34.8M.

Buyers outnumbered sellers: 18 funds opened new MRNS positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Canaan Partners VII, opening a new position worth an estimated $19M.

  • 18 institutional investors held Marinus Pharmaceuticals, Inc (MRNS) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $34.8M of Marinus Pharmaceuticals, Inc stock for Q3 2014.
  • 18 funds opened new Marinus Pharmaceuticals, Inc positions in Q3 2014 and 0 closed out, a net change of +18 holders.
  • The largest Marinus Pharmaceuticals, Inc buyer in Q3 2014 was Canaan Partners VII, an estimated $19M added.

Based on aggregated 13F filings for Q3 2014.